This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pearlstone, D. B. Articles by Feig, B. W. Search for Related Content PubMed Articles by Pearlstone, D. B. Articles by Feig, B. W. Social Bookmarking                         What's this?

The Management of Gallbladder Cancer: Before, During, and After Laparoscopic Cholecystectomy

University of Texas M.D. Anderson Cancer Center, Houston, TX

Steven A. Curley, MD

University of Texas M.D. Anderson Cancer Center, Houston, TX

Barry W. Feig, MD

University of Texas M.D. Anderson Cancer Center, Houston, TX

Carcinoma of the gallbladder is a rare disease, but when encountered in the patient undergoing laparoscopic cholecystectomy, it can pose a number of dilemmas. Familiarity with the risk factors for malignant gallbladder disease can help identify patients in whom more extensive preoperative evaluation is warranted. When carcinoma is identified preoperatively, cholecystectomy should be performed as an open procedure. If malignancy is encountered unexpectedly during laparoscopic cholecystectomy, the procedure should be converted to an open resection to allow for appropriate evaluation of the stage of disease and appropriate surgical management. Most commonly, malignancy is identified postoperatively, only after pathological examination of the resected gallbladder. Except in rare circumstances, open reoperation is necessary to achieve an adequate curative resection. The current concerns about port site recurrence and carcinomatosis after laparoscopic resection of a gallbladder carcinoma are unwarranted based on current published data. The role of prophylactic excision or irradiation of port sites is uncertain based on current understanding of the biological behavior of the disease. Copyright © 1998 by W. B. Saunders Company

Key Words: Malignancy • neoplasm • port site recurrence • carcinomatosis.

Surgical Innovation, Vol. 5, No. 2, 121-128 (1998)
DOI: 10.1177/155335069800500207


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?